Checkpoint Therapeutics Inc
CKPT
Get informed when a big investor buys or sells
+ FollowMarket Cap$367.72M
Close$
$0.17
96.1% downside
Current Fair Value
96.1% downsideOvervalued by 96.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $367.72 Million |
|---|---|
| Enterprise Value | $334.68 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.42 |
| Beta | 1.14 |
| Outstanding Shares | 598,235 |
Return
| Return on Equity | -346.78% |
|---|---|
| Return on Assets | -165.40% |
| Return on Invested Capital | -345.70% |
Valuation & Multiples
| P/E Ratio | -0.06 |
|---|---|
| PEG | -2.6 |
| Price to Sales | - |
| Price to Book Ratio | 0.16 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -5.94 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 11, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data